SkylineDx Unveils Study on Merlin CP-GEP for Melanoma Risk
Sentinel lymph node (SLN) status alone is not sufficient as node negative patients still experience relapse and melanoma-related death. SkylineDx, an innovative diagnostics company specializing in molecular diagnostics for oncology,...